Guangdong Lifestrong Pharmacy Co., Ltd.
SZSE:301111.SZ
18.89 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 278.639 | 292.397 | 283.336 | 349.789 | 340.957 | 316.585 | 290.495 | 191.589 |
| Cost of Revenue
| 84.374 | 91.946 | 92.109 | 107.211 | 114.34 | 87.582 | 89.791 | 87.423 |
| Gross Profit
| 194.265 | 200.451 | 191.227 | 242.578 | 226.616 | 229.003 | 200.704 | 104.166 |
| Gross Profit Ratio
| 0.697 | 0.686 | 0.675 | 0.693 | 0.665 | 0.723 | 0.691 | 0.544 |
| Reseach & Development Expenses
| 7.23 | 8.442 | 9.16 | 10.867 | 10.55 | 7.817 | 7.041 | 6.915 |
| General & Administrative Expenses
| 21.772 | 9.542 | 7.476 | 12.108 | -18.845 | -38.693 | -34.783 | -12.388 |
| Selling & Marketing Expenses
| 110.138 | 138.449 | 137.833 | 144.036 | 127.838 | 121.082 | 104.926 | 44.694 |
| SG&A
| 131.909 | 123.633 | 145.309 | 156.144 | 108.993 | 82.389 | 70.143 | 32.306 |
| Other Expenses
| 54.242 | 0 | -8.353 | -3.539 | -3.066 | -12.455 | 0.346 | 0.34 |
| Operating Expenses
| 193.381 | 159.269 | 163.891 | 176.667 | 153.808 | 145.184 | 122.093 | 62.77 |
| Operating Income
| 0.884 | 41.182 | 43.104 | 70.263 | 72.691 | 84.152 | 74.561 | 38.466 |
| Operating Income Ratio
| 0.003 | 0.141 | 0.152 | 0.201 | 0.213 | 0.266 | 0.257 | 0.201 |
| Total Other Income Expenses Net
| -1.028 | -3.891 | 10.919 | -3.539 | -0.227 | -3.975 | 1.061 | -0.102 |
| Income Before Tax
| -0.144 | 37.291 | 34.751 | 66.725 | 72.464 | 80.177 | 74.384 | 38.364 |
| Income Before Tax Ratio
| -0.001 | 0.128 | 0.123 | 0.191 | 0.213 | 0.253 | 0.256 | 0.2 |
| Income Tax Expense
| -1.381 | 4.759 | 1.334 | 9.543 | 9.942 | 13.543 | 10.783 | 5.607 |
| Net Income
| 4.163 | 33.502 | 33.419 | 57.182 | 62.522 | 66.633 | 63.6 | 32.757 |
| Net Income Ratio
| 0.015 | 0.115 | 0.118 | 0.163 | 0.183 | 0.21 | 0.219 | 0.171 |
| EPS
| 0.03 | 0.21 | 0.21 | 0.36 | 0.39 | 0.42 | 0.53 | 0 |
| EPS Diluted
| 0.03 | 0.21 | 0.21 | 0.36 | 0.39 | 0.42 | 0.53 | 0 |
| EBITDA
| 20.357 | 51.035 | 46.999 | 81.637 | 84.005 | 103.527 | 83.178 | 57.398 |
| EBITDA Ratio
| 0.073 | 0.175 | 0.166 | 0.233 | 0.246 | 0.327 | 0.286 | 0.3 |